These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18220982)

  • 1. Targeting the viral nucleocapsid protein in anti-HIV-1 therapy.
    de Rocquigny H; Shvadchak V; Avilov S; Dong CZ; Dietrich U; Darlix JL; Mély Y
    Mini Rev Med Chem; 2008 Jan; 8(1):24-35. PubMed ID: 18220982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification by high throughput screening of small compounds inhibiting the nucleic acid destabilization activity of the HIV-1 nucleocapsid protein.
    Shvadchak V; Sanglier S; Rocle S; Villa P; Haiech J; Hibert M; Van Dorsselaer A; Mély Y; de Rocquigny H
    Biochimie; 2009 Jul; 91(7):916-23. PubMed ID: 19401213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV-1 replication by a bis-thiadiazolbenzene-1,2-diamine that chelates zinc ions from retroviral nucleocapsid zinc fingers.
    Pannecouque C; Szafarowicz B; Volkova N; Bakulev V; Dehaen W; Mély Y; Daelemans D
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1461-8. PubMed ID: 20124006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains.
    Mori M; Kovalenko L; Malancona S; Saladini F; De Forni D; Pires M; Humbert N; Real E; Botzanowski T; Cianférani S; Giannini A; Dasso Lang MC; Cugia G; Poddesu B; Lori F; Zazzi M; Harper S; Summa V; Mely Y; Botta M
    ACS Chem Biol; 2018 Jan; 13(1):253-266. PubMed ID: 29235845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleocapsid Protein: A Desirable Target for Future Therapies Against HIV-1.
    Mori M; Kovalenko L; Lyonnais S; Antaki D; Torbett BE; Botta M; Mirambeau G; Mély Y
    Curr Top Microbiol Immunol; 2015; 389():53-92. PubMed ID: 25749978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in targeting nucleocapsid-nucleic acid interactions in HIV-1 therapy.
    Garg D; Torbett BE
    Virus Res; 2014 Nov; 193():135-43. PubMed ID: 25026536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins.
    Rice WG; Baker DC; Schaeffer CA; Graham L; Bu M; Terpening S; Clanton D; Schultz R; Bader JP; Buckheit RW; Field L; Singh PK; Turpin JA
    Antimicrob Agents Chemother; 1997 Feb; 41(2):419-26. PubMed ID: 9021201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HIV-1 nucleocapsid zinc finger protein as a target of antiretroviral therapy.
    Musah RA
    Curr Top Med Chem; 2004; 4(15):1605-22. PubMed ID: 15579099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral Activity.
    Humbert N; Kovalenko L; Saladini F; Giannini A; Pires M; Botzanowski T; Cherenok S; Boudier C; Sharma KK; Real E; Zaporozhets OA; Cianférani S; Seguin-Devaux C; Poggialini F; Botta M; Zazzi M; Kalchenko VI; Mori M; Mély Y
    ACS Infect Dis; 2020 Apr; 6(4):687-702. PubMed ID: 32045204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and structural characterization of 2-amino-4-phenylthiazole inhibitors of the HIV-1 nucleocapsid protein with antiviral activity.
    Mori M; Nucci A; Lang MC; Humbert N; Boudier C; Debaene F; Sanglier-Cianferani S; Catala M; Schult-Dietrich P; Dietrich U; Tisné C; Mely Y; Botta M
    ACS Chem Biol; 2014 Sep; 9(9):1950-5. PubMed ID: 24988251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins.
    Huang M; Maynard A; Turpin JA; Graham L; Janini GM; Covell DG; Rice WG
    J Med Chem; 1998 Apr; 41(9):1371-81. PubMed ID: 9554870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory Effect of Lithospermic Acid on the HIV-1 Nucleocapsid Protein.
    Mori M; Ciaco S; Mély Y; Karioti A
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33233563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific zinc-finger architecture required for HIV-1 nucleocapsid protein's nucleic acid chaperone function.
    Williams MC; Gorelick RJ; Musier-Forsyth K
    Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8614-9. PubMed ID: 12084921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of Natural Compounds in Licorice and Turmeric with HIV-NCp7 Zinc Finger Domain: Potential Relevance to the Mechanism of Antiviral Activity.
    Wang R; Wei Y; Wang M; Yan P; Jiang H; Du Z
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34200973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers.
    Turpin JA; Song Y; Inman JK; Huang M; Wallqvist A; Maynard A; Covell DG; Rice WG; Appella E
    J Med Chem; 1999 Jan; 42(1):67-86. PubMed ID: 9888834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental determination and calculations of redox potential descriptors of compounds directed against retroviral zinc fingers: Implications for rational drug design.
    Topol IA; McGrath C; Chertova E; Dasenbrock C; Lacourse WR; Eissenstat MA; Burt SK; Henderson LE; Casas-Finet JR
    Protein Sci; 2001 Jul; 10(7):1434-45. PubMed ID: 11420445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtle alterations of the native zinc finger structures have dramatic effects on the nucleic acid chaperone activity of human immunodeficiency virus type 1 nucleocapsid protein.
    Guo J; Wu T; Kane BF; Johnson DG; Henderson LE; Gorelick RJ; Levin JG
    J Virol; 2002 May; 76(9):4370-8. PubMed ID: 11932404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,2'-Dithiobisbenzamides and 2-benzisothiazolones, two new classes of antiretroviral agents: SAR and mechanistic considerations.
    Domagala JM; Gogliotti R; Sanchez JP; Stier MA; Musa K; Song Y; Loo J; Reily M; Tummino P; Harvey P; Hupe D; Sharmeen L; Mack D; Scholten J; Saunders J; McQuade T
    Drug Des Discov; 1997 May; 15(1):49-61. PubMed ID: 9332831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strict conservation of the retroviral nucleocapsid protein zinc finger is strongly influenced by its role in viral infection processes: characterization of HIV-1 particles containing mutant nucleocapsid zinc-coordinating sequences.
    Gorelick RJ; Gagliardi TD; Bosche WJ; Wiltrout TA; Coren LV; Chabot DJ; Lifson JD; Henderson LE; Arthur LO
    Virology; 1999 Mar; 256(1):92-104. PubMed ID: 10087230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flexible nature and specific functions of the HIV-1 nucleocapsid protein.
    Darlix JL; Godet J; Ivanyi-Nagy R; Fossé P; Mauffret O; Mély Y
    J Mol Biol; 2011 Jul; 410(4):565-81. PubMed ID: 21762801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.